Philip Charles Hoffman to Doxorubicin
This is a "connection" page, showing publications Philip Charles Hoffman has written about Doxorubicin.
Connection Strength
0.012
-
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
Score: 0.006
-
Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP. Leukemia. 1990 Feb; 4(2):127-31.
Score: 0.005